Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease  by Leeper, Nicholas J. et al.
Exercise capacity is the strongest predictor of
mortality in patients with peripheral arterial disease
Nicholas J. Leeper, MD,a Jonathan Myers, PhD,b Margaret Zhou, BS,c Kevin T. Nead, BS,c
Arshiya Syed, MD,b Yoko Kojima, MD, PhD,a Roxanne Diaz Caceres, BS,a and
John P. Cooke, MD, PhD,c Stanford, Calif
Objective:The objective of this study was to assess the predictive value of clinical and exercise test variables in patients with
peripheral arterial disease (PAD).
Methods: A customized symptom-limited ramp treadmill protocol was used to assess 725 PAD patients referred for
exercise testing at the Palo Alto Veterans Hospital between 1997 and 2011. Detailed clinical and exercise test data were
collected at baseline, and patients were followed up for a mean of 11.3  6.3 years.
Results:During follow-up, there were 364 deaths. Baseline exercise capacity was 7.0 2.6 metabolic equivalents (METs)
among survivors and 5.5  2.4 METs in those who died (P < .001). Although several physiologic parameters differed
between survivors and nonsurvivors, age-adjusted Cox regression revealed that exercise capacity was the strongest
independent predictor of death. Each additional MET achieved was associated with age-adjusted 18% and 20% reductions
in all-cause and cardiovascular mortality, respectively (P< .001 for both). This variable surpassed all classical risk factors
(including smoking and history of congestive heart failure) and all measured exercise test responses (including symptoms
and electrocardiograph abnormalities).
Conclusions: Among PAD patients, reduced exercise capacity is the most powerful harbinger of long-term mortality. This
factor has predictive power beyond traditional risk factors and confirms the critical importance of fitness in this cohort.
(J Vasc Surg 2013;57:728-33.)
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sRecent efforts have focused on identifying improved
prognostic indicators for patients with atherosclerotic dis-
ease. The aim of this approach is to identify those who stand
to benefit the most from aggressive risk factor reduction
and directed therapies. Exercise testing has been an area of
intense focus, given its relatively low cost, noninvasive
nature, and ability to provide prognostic information be-
yond traditional risk factor assessment.1 In a number of
recent studies, exercise capacity has been a particularly
powerful predictor of death and other adverse events. Ex-
ercise capacity has been shown to be the strongest predictor
of all-cause and cardiovascular death in elderly individuals,
those with hypertension, and those that are obese.2-4 Re-
markably, this single variable provided more prognostic
information than each of the classical risk factors or even the
Framingham risk score.4
To our knowledge, the association between survival
and exercise capacity during standardized treadmill exercise
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728esting has not been evaluated in patients with peripheral
rterial disease (PAD). Accordingly, we aimed to study the
ssociation between simple physiologic parameters and
ong-term survival in a large cohort of PAD patients from
he Veterans Exercise Testing Study (VETS). Our ultimate
oal was to define exercise test parameters that could
dentify patients at risk, compare these with traditional risk
actors, and provide important prognostic information to
ndividuals with vascular disease.
ETHODS
The VETS cohort is an ongoing, prospective evaluation
f veterans referred for exercise testing for clinical reasons
nd is designed to address exercise test, clinical, and lifestyle
actors and their association with health outcomes.2,5,6
rom the VETS cohort, a list of approximately 10,000male
eterans who had undergone a maximal treadmill test for
linical reasons at the Veterans Affairs (VA) Palo Alto
ealth Care System between 1997 and 2011 for clinical
ndications was formed. This list was used to query the VA
omputerized database to identify patients with a history of
AD entered at the time the exercise test was performed.
he search identified 725 veterans who had PAD by his-
ory, by claudication during their exercise test, or both.
istorical information that was recorded at the time of the
xercise test included previous myocardial infarction by
istory or Q wave, cardiac procedures, heart failure, hyper-
ension, hypercholesterolemia (220 mg/dL), intermit-
ent claudication, chronic obstructive pulmonary disease,
ancer, end-stage renal disease, diabetes, stroke, smoking
tatus (current, past), and use of cardiac medications (cat-
goric only, anticoagulants were not differentiated).
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Volume 57, Number 3 Leeper et al 729The current study evaluated only data available at the
baseline visit as part of a clinically referred exercise test and
the association of these data with cardiovascular and all-
cause mortality. Clinical and historical variables were de-
fined in a standard fashion through a history and physical
examination performed at the time of the test by a cardiol-
ogy fellow, and this historical information was confirmed
by computerized records. The exercise test interpretation
was over-read by an attending physician.
Exercise testing. Patients underwent symptom-
limited treadmill testing using an individualized ramp
treadmill protocol such that the test duration was targeted
to fall within the recommended 8- to 12-minute range, as
previously described.1,7 Electrocardiograms (ECGs) were
obtained at rest, each minute during exercise, and for at
least 8 minutes during recovery. Blood pressure was mea-
sured at rest, every minute during exercise, and at 1, 2, 5,
and 8 minutes during recovery or until symptoms, ECG
changes, and blood pressure stabilized. Standard criteria for
termination were used, including moderately severe an-
gina, 2.0-mm abnormal ST depression, or a sustained
drop in systolic blood pressure or serious rhythm distur-
bances. In the absence of clinical indications for stopping,
participants were encouraged to exercise until volitional
fatigue, and the Borg 6 to 20 perceived exertion scale was
used to quantify degree of effort.8,9 Blood pressure was
Table I. Clinical and demographic characteristics of the sa
Variablesa All (n  725) Surv
Demographics
Age, years 62.0  9.1 5
Follow-up years 11.3  6.25 1
Height, inches 68.9  3.2 6
Weight, pounds 186.8  36.7 19
Sex
Male 708 (97.7) 3
Female 18 (2.3)
Clinical history
Diabetes 113 (15.6)
Hypertension 468 (64.6) 2
Claudication 496 (68.4) 2
Heart failure 61 (8.4)
Stroke 49 (6.8)
Pulmonary disease 102 (14.1)
Smoking history 486 (67) 2
Pack-years smoking 32.8  32.3 3
Hyperlipidemia 283 (39) 1
Cholesterol, mg/dL 205.3  54.5
HDL, mg/dL 43.4  17.3 4
Medications
Digoxin 56 (7.7)
-blockers 183 (25.2) 1
Calcium antagonist 286 (39.4) 1
Nitrates 239 (33)
Antihypertensives 233 (32.1)
Antiarrhythmics 18 (2.5)
ACE inhibitors 116 (16)
Anticoagulants 172 (23.7) 1
ACE, Angiotensin-converting enzyme; HDL, high-density lipoprotein; NS,
aContinuous data are shown as mean  standard deviation and categoric dataken manually, and exercise capacity in metabolic equiva- oents (METs) was estimated from peak treadmill speed and
rade.10
No test was classified as incomplete or indeterminate,
edications were not withheld, and age-predicted maximal
arget heart rates were not used as end points. The exercise
ests were performed, analyzed, and reported using a stan-
ard protocol incorporating a computerized database, with
ll definitions and measurements prospectively defined.11
Outcomes. The main outcome variable was all-cause
ortality, and cardiovascular death was also recorded. The
alifornia Health Department Service and Social Security
eath Indexes were used to ascertain the vital status of each
atient as of December 31, 2011. Accuracy of deaths was
eviewed by two clinicians blinded to exercise test results
nd confirmed using the VA computerized medical re-
ords.
Statistical analysis. NCSS software (Kayesville, Utah)
as used for all statistical analyses. Unpaired t-tests were
sed for comparisons of continuous variables, and 2 tests
ere used to compare dichotomous variables between pa-
ients who survived and those who died. Cox proportional
azards analysis was performed to determine which clinical
nd exercise test variables were independently associated
ith all-cause and cardiovascular mortality. Survival analy-
es were adjusted for age. Hazard ratios (HR) were calcu-
ated alongwith their 95% confidence intervals (CI). Receiver-
n  361) Nonsurvivors (n  364) P
8.4 64.6  8.4 .001
4.8 7.5  5 .001
3.3 69  3.2 .42
38.5 182.2  34.2 .001
97) 358 (98.4) .69
3) 6 (1.6) .69
16.3) 54 (14.8) .58
65.9) 230 (63.1) .44
69.3) 246 (67.6) .63
4.4) 45 (12.4) .001
5.5) 29 (8.0) .19
13.9) 52 (14.3) .87
71.7) 227 (62.4) .007
30.3 33.3  34.2 .68
44.6) 122 (33.5) .001
57 196.4  47.5 .16
18.8 45.0  13.6 .47
5.8) 35 (9.6) .05
28.5) 80 (22) .04
36) 156 (42.9) .05
25.8) 146 (40.1) .001
26.9) 136 (37.4) .002
0.6) 16 (4.4) .001
23) 33 (9.1) .001
33.2) 52 (14.3) .001
ignificant.
umber (%).mple
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March 2013730 Leeper et aldetermine the discriminatory accuracy of exercise capacity and
other key variables to predict survival. An exploratory univar-
iate survival analysis was initially performed, and the strongest
univariate predictors of risk were entered into a stepwise
multivariate analysis. Kaplan-Meier curves were constructed
to assess overall survival with time and to compare survival
among participants with high and low exercise capacity. The
log-rank testwas used to compareKaplan-Meier curves.Mean
data are presented with the standard deviation.
RESULTS
The sample included the 708 men and 17 women with
PAD. Their mean age was 62.0  9.1 years. The mean
follow-up period was 11.3 6.3 years, and there were 364
deaths (50.2% of the total sample), for an average annual
mortality of 4.4%; 36.3% of the deaths were due to cardio-
vascular causes. Baseline demographic variables, clinical
history, and medications in the entire cohort and between
those who survived and those who died are presented in
Table I.
A comparison of exercise test responses between those
who died and those who survived is presented in Table II.
Maximal heart rate (130 21 vs 122 23 beats/min; P
.001) and exercise capacity (7.0 2.6 vs 5.5 2.4 METs;
P .001) were higher among those who survived, whereas
the proportion of participants with an abnormal resting
Table II. Exercise test responses
Variablesa All (n  725) S
Resting
Heart rate, beats/min 77  15
Blood pressure, mm Hg
Sytolic 137  22
Diastolic 80  12
Maximal
Heart rate, beats/min 126  22
Blood pressure, mm Hg
Sytolic 175  29
Diastolic 87  33
Heart rate recovery, 2 minutes 95  21
Exercise capacity, METs 6.23  2.6
Peak perceived exertion 17  2
Electrocardiogram
Normal resting 273 (37.7)
Abnormal resting 331 (45.7)
Reasons for stopping exerciseb
Angina 149 (20.6)
Fatigue 103 (14.2)
Shortness of breath 82 (11.3)
Leg fatigue 76 (10.5)
Claudication 483 (66.6)
Other leg pain 77 (10.6)
Submaximal target 21 (2.9)
Dysrhythmias 61 (8.4)
ST changes 35 (4.8)
Other chest pain 12 (1.7)
Hypotension 14 (1.9)
METs, Metabolic equivalents.
aContinuous data are shown as mean  standard deviation and categoric da
bNote that more than one reason for stopping may be recorded.ECG was higher among those who died (34.3% vs 56.9%;  .001). A higher proportion of nonsurvivors was limited
y claudication, experienced rhythm abnormalities, and
ad a hypotensive response to exercise; however, ischemic
esponses were similar between groups.
Univariate predictors of all-cause mortality were age,
xercise capacity, pack-years of smoking, history of heart
ailure, maximal heart rate, and maximal systolic blood
ressure. Age-adjusted multivariate proportional hazards
nalysis for both all-cause and cardiovascular mortality as
he outcome is presented in Table III. Exercise capacity was
he strongest predictor of all-cause mortality (HR, 0.83;
5% CI, 0.79-0.88; P  .001; area under the ROC curve,
.64). Exercise capacity remained the strongest predictor
hen adjusted for age (HR, 0.85; 95% CI, 0.81-0.90; P 
001). The only other predictors of all-cause mortality were
ack-years of smoking (HR, 1.01; 95% CI, 1.0-1.01; P 
001) and history of heart failure (HR, 1.92; 95% CI,
.34-2.76; P  .001; area under the ROC curve, 0.54).
imilarly, the strongest predictor of cardiovascular mortal-
ty was exercise capacity. An age-adjusted 20% reduction
ardiovascular mortality was observed for each MET
chieved. The only other predictors of cardiovascular mor-
ality were age and history of heart failure.
Fig 1 illustrates overall survival across the follow-up and
ompares participants who achieved 5 METs and 5
ETs for exercise capacity. Survival among those achieving
ors (n  361) Nonsurvivors (n  364) P
7  15 77  15 .99
5  21 138  23 .14
0  12 80  11 .88
0  21 122  23 .001
8  28 173  30 .009
6  15 87  44 .8
6  20 89  22 .25
.0  2.6 5.5  2.4 .001
7  2 17  3 .07
4 (45.4) 109 (29.9) .001
4 (34.3) 207 (56.9) .001
7 (21.3) 72 (19.8) .74
6 (18.3) 37 (10.2) .001
4 (15) 28 (7.7) .002
8 (13.3) 28 (7.7) .01
7 (62.9) 256 (70.3) .03
5 (12.5) 32 (8.8) .11
7 (1.9) 14 (3.8) .13
7 (4.7) 44 (12.1) .001
3 (3.6) 22 (6) .12
8 (2.2) 4 (1.1) .24
2 (0.6) 12 (3.3) .007
umber (%).urviv
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Volume 57, Number 3 Leeper et al 731exercise capacity (P .001). Age-adjusted relative risks for
cardiovascular and all-cause mortality based on quartiles of
exercise capacity are presented in Fig 2. For both outcomes,
relative risks decreased as exercise capacity increased (P 
.001 for trend); the greatest outcome benefits were ob-
Table III. Multivariate proportional hazards analysis for
each predictor alone and then combined
Predictor HR (95% CI)
Regression
coefficient P
All-cause mortality
Model 1
Exercise capacity 0.83 (0.79-0.88) –0.18 .001
Model 2
Age 1.03 (1.01-1.04) 0.03 .001
Exercise capacity 0.85 (0.81-0.90) 0.15 .001
Model 3
Age 1.03 (1.01-1.04) 0.03 .001
Exercise capacity 0.85 (0.81-0.90) 0.16 .001
Pack-years 1.01 (1.00-1.01) 0.006 .001
Model 4
Age 1.03 (1.01-1.05) 0.03 .001
Exercise capacity 0.87 (0.82-0.91) 0.14 .001
Pack-years 1.01 (1.0-1.01) 0.005 .001
Heart failure history 1.92 (1.34-2.76) 0.65 .001
Cardiovascular
mortality
Model 1
Exercise capacity 0.80 (0.73-0.87) 0.22 .001
Model 2
Age 1.03 (1.01-1.06) 0.03 .02
Exercise capacity 0.82 (0.75-0.90) 0.19 .001
Model 3
Age 1.03 (1.01-1.06) 0.03 .007
Exercise capacity 0.84 (0.76-0.92) 0.18 .001
Heart failure history 2.24 (1.3-3.9) 0.81 .004
CI, Confidence interval; HR, hazard ratio.
Fig 1. Kaplan-Meier curve shows cumulative survival among par-
ticipants achieving 5 metabolic equivalents (METs) and those
achieving 5 METs. Numbers given along the curves are patients
at risk at each interval; numbers in parentheses are standard errors
(*standard error [SE] 10%). P  .001 between groups.served between the least fit group (4METs) and quartiles iand 3 (4-6 and 6-8 METs, respectively), whereas the two
ighest-fit quartiles had similar mortality rates.
ISCUSSION
In this report, we show for the first time that total
xercise capacity, defined as METs achieved during a tread-
ill exercise test, is the strongest predictor of survival
mong clinical and exercise test variables in a large cohort of
atients with PAD. We observed that this factor predicts
ardiovascular and all-cause mortality and is independent of
ther traditional risk factors and measured exercise param-
ters. Similar to patients with other forms of cardiovascular
isease,3 we observed an age-adjusted 17% reduction in
otal mortality and an age-adjusted 20% reduction in car-
iovascular mortality with each additional MET achieved
n a treadmill test. To our knowledge, the prognostic value
f this exercise test parameter has not previously been
eported in patients with PAD, and these findings support
he routine use of exercise capacity when evaluating these
atients.
Several prior studies have documented a therapeutic
ole for exercise in PAD,12-14 but few have assessed the role
f exercise capacity as a prognosticator in this patient
opulation. de Liefde et al15 reported that a hypertensive
esponse to exercise was associated with adverse outcomes
n PAD patients. However, their study used a single-stage
ubmaximal test and did not assess maximal exercise capac-
ig 2. Relative risks for (top) all-cause mortality and (bottom)
ardiovascular mortality according to quartiles of exercise capacity
s measured by metabolic equivalents (METs). P .001 for trend.ty. In the current study, a hypertensive response to exercise
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March 2013732 Leeper et alwas not found to be a predictive factor. McDermott et
al16,17 recently showed that several office-based measures
of walking could predict survival, but they did not directly
assess overall fitness or exercise capacity, parameters that
have been shown to be highly predictive in other cohorts,
including patients suspected of having coronary disease,
patients with heart failure, and healthy individuals.1-6,18
In our study, we observed that simply moving from the
lowest quartile of cardiovascular fitness into the next lowest
category was associated with 20% to 30% reductions in
cardiovascular and all-cause mortality. From an epidemio-
logic perspective, this association between a modest differ-
ence in fitness level and higher rates of survival is quantita-
tively greater than the benefits derived from the best known
interventions for PAD. In fact, exercise capacity was supe-
rior to all other factors measured in the current study. On
the basis of the significant prognostic power of this single
variable, we believe that exercise capacity should be given as
much consideration as traditional risk factors, especially
when considering the likelihood of long-term survival in
the PAD patient.
Our results are consistent with recent evidence that has
linked PAD to a lifetime of physical inactivity. The seden-
tary state is a known risk factor for major adverse cardiovas-
cular events.2,19 Individuals with PAD are known to be
relatively sedentary, and it has been assumed that the limi-
tations of impaired limb perfusion were responsible for
their reduced physical activity. However, most patients
with PAD do not complain of intermittent claudication,20
which has been attributed in part to their lack of activity.
Most recently, we found in a cohort of 1381 individuals
referred for cardiac catheterization that lifetime physical
activity (as assessed by a standardized and validated ques-
tionnaire) was positively correlated to the ankle-brachial
index.21 Individuals in the quintile with the least lifetime
recreational activity had twice the risk of PAD compared
with those with the most activity. Notably, the reduction in
the prevalence of PAD with increasing activity was not
linear; the largest reduction occurred between the group
with essentially no recreational activity and the next least
active group. Thus, PAD may partly be a manifestation of
the sedentary state.19 Taken together, it is becoming in-
creasingly clear that identifying those with the lowest exer-
cise capacity is important not only to help predict the
presence and severity of PAD but also to prognosticate the
future risk of death.
We did not directly test the hypothesis that raising an
individual’s achievableMET level through exercise training
could reclassify the person into a lower-risk category. In
addition, fitness is an attribute (not a behavior) that has a
strong genetic component.22 However, physical activity is
the only known method for developing overall fitness,
and prior studies have shown that supervised exercise
training has the added benefit of reducing claudication
symptoms and extending walking distance among PAD
patients.12,13,23 Future prospective randomized studies
are indicated to measure whether exercise programs canot only improve quality of life14 but also reduce mor-
idity and mortality in this high-risk cohort.
This report has several limitations that warrant consid-
ration. Our cohort consisted primarily of men, and there-
ore, the prognostic utility of exercise capacity in women is
ot defined. It is worth noting, however, that a recent
eta-analysis of exercise testing studies in both men and
omen showed that achieved METs was equally powerful
n healthy participants of each sex.3 Also, ankle-brachial
ndices were not recorded at the time of exercise testing;
hus, we could not ascertain an interaction between severity
f PAD and the prognostic capacity of the exercise test,
lthough the ankle-brachial index has previously been
hown to correlate weakly with pain-free walking.24 Finally,
nrollment for this study began nearly 15 years ago, and
any participants were prescribed a regimen that would
ot be considered maximal medical therapy by today’s
tandards. Thus, it is not clear if a “modern” medical
egimen would attenuate the observed association or if it
ould continue to have predictive capacity, as reported in
ther cohorts.
ONCLUSIONS
This study shows the prognostic utility of exercise
apacity for the patient with PAD. Exercise capacity on a
tandardized exercise test is more predictive of long-term
urvival than any traditional risk factor or other measured
hysiologic parameter. These results raise the hope that
vent-free survival might be increased in these patients by
ncreasing their exercise capacity and suggest this as an area
f future study.
We acknowledge the contributions of Shyam Panchal,
oshua Abella, and Vic Froelicher for their help with the
ata collection and treadmill test interpretation.
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